Medolife Rx Submits Final Data Set to FDA for IND Filing on Lead Drug Candidate
13 avr. 2021 08h30 HE
|
Quanta, Inc.
BURBANK, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
Melt Pharmaceuticals Enters the Clinical Stage of MELT-100 Development
29 juil. 2020 07h00 HE
|
Melt Pharmaceuticals
FDA has accepted MELT-100 IND; Phase 1 study enrollment to start immediately BOSTON, July 29, 2020 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing...